Risedronate and blood bilirubin increased 
Risedronate and blood bilirubin increased Patient Reports February 12, 2012
Risedronate Side Effects Report #5890688-0
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 73 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, decreased appetite, gastritis erosive, jaundice , liver disorder. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, ASPARA, ZOLPIDEM TARTRATE, ETODOLAC, METHYCOBAL, SOLON, CRESTOR, EPADEL. Patient recovered.Risedronate Side Effects Report #5140802-X
Risedronate side effect was reported by a Physician from JAPAN on Oct 19, 2006. Female patient, 71 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with PENFILL R. Patient was hospitalized. Patient recovered.Risedronate Side Effects Report #4621086-5
Risedronate side effect was reported by a Physician from on Mar 14, 2005. Female patient, 64 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with VITAMIN D3, URSODIOL, MEVALOTIN. Patient was hospitalized. Patient recovered.Risedronate Side Effects Report #5003416-8
Risedronate side effect was reported by a Physician from JAPAN on Apr 26, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.Risedronate Side Effects Report #5020725-7
Risedronate side effect was reported by a Physician from JAPAN on May 12, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, metrorrhagia, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.